Latest News

Todos COVID-19 Drug Shows Superiority to Remdesivir,Takes Dying Off the Table

43 views0
By
Share

February 9, 2022 (Investorideas.com Newswire) In a phase 2 clinical study, Todos Medical’s oral antiviral Tollovir showed a 100% reduction in mortality from COVID-19.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
Previous
Next

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News